Mersana Therapeutics
MRSN
#8905
Rank
ยฃ0.10 B
Marketcap
ยฃ21.13
Share price
0.79%
Change (1 day)
-57.74%
Change (1 year)

Revenue for Mersana Therapeutics (MRSN)

Revenue in 2025 (TTM): ยฃ26.81 Million

According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ26.11 Million. In 2024 the company made a revenue of ยฃ32.27 Million an increase over the revenue in the year 2023 that were of ยฃ28.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mersana Therapeutics from 2016 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ26.81 M-16.91%
2024 ยฃ32.27 M11.55%
2023 ยฃ28.92 M31.66%
2022 ยฃ21.97 M67304.14%
2021 ยฃ0.03 M-94.64%
2020 ยฃ0.6 M-98.11%
2019 ยฃ32.12 M284.86%
2018 ยฃ8.34 M-35.7%
2017 ยฃ12.98 M-36.36%
2016 ยฃ20.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA